Literature DB >> 8128960

The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease.

C E Yu1, H Payami, J M Olson, M Boehnke, E M Wijsman, H T Orr, W A Kukull, K A Goddard, E Nemens, J A White.   

Abstract

The chromosome 19 apolipoprotein E/CI/CII gene cluster was examined for evidence of linkage to a familial Alzheimer disease (FAD) locus. The family groups studied were Volga German (VG), early-onset non-VG (ENVG; mean age at onset < 60 years), and late-onset families. A genetic association was observed between apolipoprotein E (ApoE) allele epsilon 4 and FAD in late-onset families; the epsilon 4 allele frequency was .51 in affected subjects, .37 in at-risk subjects, .11 in spouses, and .19 in unrelated controls. The differences between the epsilon 4 frequencies in affected subjects versus controls and in at-risk subjects versus controls were highly significant (standard normal deviate [ZSND]) = 7.37, P < 10(-9); and ZSND = 4.07, P < .00005, respectively). No association between the epsilon 4 allele and FAD was observed in the ENVG or VG groups. A statistically significant allelic association between epsilon 4 and AD was also observed in a group of unrelated subjects; the epsilon 4 frequency was .26 in affected subjects, versus .19 in controls (ZSND = 2.20, P < .03). Evidence of linkage of ApoE and ApoCII to FAD was examined by maximum-likelihood methods, using three models and assuming autosomal dominant inheritance: (1) age-dependent penetrance, (2) extremely low (1%) penetrance, and (3) age-dependent penetrance corrected for sporadic Alzheimer disease (AD). For ApoCII in late-onset families, results for close linkage were negative, and only small positive lod-score-statistic (Z) values were obtained (model 1, maximum Z[Zmax] = 0.61, recombination fraction [theta] = .30; model 2, Zmax = 0.47, theta = .20). For ApoE in late-onset kindreds, positive Z values were obtained when either allele frequencies from controls (model 1, Zmax = 2.02, theta = .15; model 2, Zmax = 3.42, theta = .05) or allele frequencies from the families (model 1, Zmax = 1.43, theta = .15; model 2, Zmax = 1.70, theta = .05) were used. When linkage disequilibrium was incorporated into the analysis, the Z values increased (model 1, Zmax = 3.17, theta = .23; model 3, Zmax = 1.85, theta = .20). For the ENVG group, results for ApoE and ApoCII were uniformly negative. Affected-pedigree-member analysis gave significant results for the late-onset kindreds, for ApoE (ZSND = 3.003, P = .003) and ApoCII (ZSND = 2.319, P = .016), when control allele frequencies were used but not when allele frequencies were derived from the families.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8128960      PMCID: PMC1918105     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  52 in total

1.  Interaction of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors.

Authors:  R W Mahley; K H Weisgraber; T L Innerarity
Journal:  Biochim Biophys Acta       Date:  1979-10-26

2.  The affected-pedigree-member method of linkage analysis.

Authors:  D E Weeks; K Lange
Journal:  Am J Hum Genet       Date:  1988-02       Impact factor: 11.025

3.  Effects of misspecifying genetic parameters in lod score analysis.

Authors:  F Clerget-Darpoux; C Bonaïti-Pellié; J Hochez
Journal:  Biometrics       Date:  1986-06       Impact factor: 2.571

4.  X-linkage: ascertainment through doubly ill probands.

Authors:  E S Gershon; S Matthysse
Journal:  J Psychiatr Res       Date:  1977       Impact factor: 4.791

5.  Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of age.

Authors:  R C Mohs; J C Breitner; J M Silverman; K L Davis
Journal:  Arch Gen Psychiatry       Date:  1987-05

6.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

7.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type.

Authors:  G D Schellenberg; S S Deeb; M Boehnke; E M Bryant; G M Martin; T H Lampe; T D Bird
Journal:  J Neurogenet       Date:  1987-04       Impact factor: 1.250

Review 9.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

10.  Sulfated glycosaminoglycans: a common constituent of all amyloids?

Authors:  A D Snow; J Willmer; R Kisilevsky
Journal:  Lab Invest       Date:  1987-01       Impact factor: 5.662

View more
  20 in total

1.  Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice.

Authors:  X Bi; A P Yong; J Zhou; C E Ribak; G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.

Authors:  H Payami; H Grimslid; B Oken; R Camicioli; G Sexton; A Dame; D Howieson; J Kaye
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

3.  A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping or DNA sequencing. V. Analysis of case/control sampling designs: Alzheimer's disease and the apoprotein E locus.

Authors:  A R Templeton
Journal:  Genetics       Date:  1995-05       Impact factor: 4.562

4.  Aluminum and Alzheimer's disease.

Authors:  D G Munoz
Journal:  CMAJ       Date:  1995-02-15       Impact factor: 8.262

5.  Model-free linkage analysis using likelihoods.

Authors:  D Curtis; P C Sham
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

6.  Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.

Authors:  C R Harrington; J Louwagie; R Rossau; E Vanmechelen; R H Perry; E K Perry; J H Xuereb; M Roth; C M Wischik
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

7.  Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.

Authors:  T Wisniewski; E M Castaño; A Golabek; T Vogel; B Frangione
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

8.  Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disease.

Authors:  R Egensperger; S Kösel; R Schnabel; P Mehraein; M B Graeber
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia.

Authors:  M G Martinoli; J Q Trojanowski; M L Schmidt; S E Arnold; T M Fujiwara; V M Lee; H Hurtig; J P Julien; C Clark
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Evidence for familial factors that protect against dementia and outweigh the effect of increasing age.

Authors:  H Payami; K Montee; J Kaye
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.